9.400
+0,00%
2026-10-19
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -42.5% | +30737.3% | 2 / 3 | -29.1% | +0.55 pp | -0.17 pp | +14.6% | 0.00 | 4.97 | 563 | −29,1% | 4,1 | −42,5% | 4.97 | 6.72 | −26,1% |
| Pts | 0 | 12 | 8 | 0 | 8 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 9.400 (close price on 2026-10-19)EPS (TTM): 1.893
Financial charts
1.Revenue & growth
VND bn563Q2/26
1.Revenue & growth
VND bn563Q2/26
2.Profit & growth
VND bn4,08Q2/26
3.Profit mix (Penman)
VND bn28,6Q2/26
4.Margins & cost structure
%3.8%Q2/26
5.Returns & cash cycle
% · days1992%Q2/26
6.Earnings quality & cash
VND bn-16,3Q2/26
7.Asset structure
VND bn319Q2/26
8.Funding & debt health
VND bn · times319Q2/26
9.Revenue backlog
VND bn70,4Q2/26
10.Valuation
times · %5,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %340Q2/26
Adjusted EPS growth, latest quarter
-42.5%
Average adjusted EPS growth, 3 quarters
11.4%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26